Dihydroartemisinin-Piperaquine vs. Artemether-Lumefantrine for First-Line Treatment of Uncomplicated Malaria in African Children: A Cost-Effectiveness Analysis (original) (raw)
Figure 2
Scatterplot of incremental costs and effectiveness for DP vs. AL for first-line treatment of uncomplicated P. falciparum malaria in young children based on probabilistic sensitivity analysis (10,000 iterations) (all values are calculated per child over one year).
DP = Dihydroartemisinin-Piperaquine; AL = Artemether-Lumefantrine; DALY = Disability-Adjusted Life Year.